M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down By: Benzinga via Benzinga December 14, 2015 at 11:59 AM EST Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to ... Read More >> Related Stocks: Amgen Astrazeneca Plc ADR Celgene Corp Gilead Sciences Macy's Shire Plc Ads